U.S. Pharmaceutical Sales - Q4 2011

The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q4 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q4 2011 by Sales

Rank Drug Sales ($000)
1 Lipitor
Pfizer Inc
-18.69% Stats
2 Plavix
Bristol-Myers Squibb Company
-3.38% Stats
3 Nexium
AstraZeneca Pharmaceuticals, LP
-0.10% Stats
4 Abilify
Otsuka Pharmaceutical Co., Ltd
2.66% Stats
5 Singulair
Merck & Co., Inc.
2.59% Stats
6 Seroquel
AstraZeneca Pharmaceuticals, LP
1.71% Stats
7 Advair Diskus
GlaxoSmithKline
5.66% Stats
8 Crestor
AstraZeneca Pharmaceuticals, LP
3.69% Stats
9 Cymbalta
Eli Lilly and Company
4.70% Stats
10 (1) Humira
AbbVie, Inc.
3.18% Stats
11 (1) Enbrel
Amgen Inc.
1.67% Stats
12 (2) Neulasta
Amgen Inc.
4.59% Stats
13 (3) Remicade
Centocor Ortho Biotech, Inc
-7.02% Stats
14 (2) Rituxan
Genentech, Inc (member of Roche group)
6.96% Stats
15 (3) Lexapro
Forest Pharmaceuticals, Inc
3.12% Stats
16 (1) Copaxone
Teva Pharmaceuticals
0.98% Stats
17 (2) OxyContin
-2.58% Stats
18 (3) Actos
Takeda Pharmaceuticals U.S.A., Inc
-15.22% Stats
19 (1) Atripla
Gilead Sciences, Inc.
4.92% Stats
20 (2) Epogen
Amgen Inc.
4.67% Stats
21 Avastin
Genentech, Inc (member of Roche group)
2.86% Stats
22 (1) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
6.93% Stats
23 (1) Januvia
Merck & Co., Inc.
4.87% Stats
24 () atorvastatin
Generic
Stats
25 Truvada
Gilead Sciences, Inc.
3.43% Stats
26 (12) enoxaparin
Generic
36.13% Stats
27 (1) Lantus
Sanofi (formerly Sanofi Aventis)
0.69% Stats
28 (1) Diovan
Novartis Corporation
0.69% Stats
29 (11) Incivek
Vertex Pharmaceuticals
33.13% Stats
30 (2) Lucentis
Genentech, Inc (member of Roche group)
2.44% Stats
31 (2) Lyrica
Pfizer Inc
1.23% Stats
32 (2) Celebrex
Pfizer Inc
1.12% Stats
33 (2) Herceptin
Genentech, Inc (member of Roche group)
7.61% Stats
34 Lantus Solostar
Sanofi (formerly Sanofi Aventis)
8.54% Stats
35 (4) Eloxatin
Sanofi (formerly Sanofi Aventis)
12.60% Stats
36 (1) Gleevec
Novartis Corporation
4.38% Stats
37 (1) Namenda
Forest Pharmaceuticals, Inc
6.06% Stats
38 (5) Avonex
Biogen Idec
0.19% Stats
39 () olanzapine
Generic
Stats
40 (8) Diovan HCT
Novartis Corporation
-1.99% Stats
41 (28) Zyprexa
Eli Lilly and Company
-54.28% Stats
42 (5) OneTouch
0.66% Stats
43 (2) Vyvanse
Shire US Inc
13.05% Stats
44 (1) Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
6.35% Stats
45 (4) Geodon
Pfizer Inc
-1.27% Stats
46 (2) Zetia
Merck & Co., Inc.
2.80% Stats
47 Provigil
Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd)
9.48% Stats
48 (6) TriCor
Abbott Laboratories
-2.67% Stats
49 (3) Lidoderm
Endo Pharmaceuticals
7.01% Stats
50 (2) methylphenidate
Generic
16.12% Stats
51 () Synagis
MedImmune, Inc
Stats
52 (4) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc
10.49% Stats
53 (3) AndroGel
AbbVie, Inc.
5.44% Stats
54 (3) amphetamine/dextroamphetamine
Generic
9.03% Stats
55 (2) Procrit
Janssen Pharmaceuticals, Inc
3.58% Stats
56 (8) Symbicort
AstraZeneca Pharmaceuticals, LP
11.05% Stats
57 (28) budesonide
Generic
51.97% Stats
58 (9) Niaspan
Abbott Laboratories
-1.11% Stats
59 (4) Seroquel XR
AstraZeneca Pharmaceuticals, LP
2.27% Stats
60 (2) Alimta
Eli Lilly and Company
1.82% Stats
61 (7) Rebif
0.43% Stats
62 (3) Viagra
Pfizer Inc
1.74% Stats
63 (3) Novolog
Novo Nordisk, Inc.
0.97% Stats
64 (4) Nasonex
Merck & Co., Inc.
9.30% Stats
65 (2) Humalog
Eli Lilly and Company
3.78% Stats
66 (15) Aranesp
Amgen Inc.
-6.07% Stats
67 (5) Flovent HFA
GlaxoSmithKline
15.06% Stats
68 (1) Lovaza
GlaxoSmithKline
5.34% Stats
69 (3) ProAir HFA
Teva Pharmaceuticals
1.93% Stats
70 (5) Neupogen
Amgen Inc.
0.16% Stats
71 (10) Vytorin
Merck & Co., Inc.
-3.61% Stats
72 (2) Reyataz
Bristol-Myers Squibb Company
3.45% Stats
73 (4) metoprolol
Generic
1.20% Stats
74 (3) Adderall XR
Shire US Inc
2.80% Stats
75 (1) Levemir
Novo Nordisk, Inc.
8.66% Stats
76 (4) NovoLog FlexPen
Novo Nordisk, Inc.
10.19% Stats
77 (2) Aciphex
Eisai Corporation
-1.37% Stats
78 Isentress
Merck & Co., Inc.
6.07% Stats
79 (5) fentanyl
Generic
-2.90% Stats
80 (1) Cialis
Eli Lilly and Company
4.24% Stats
81 (19) Lovenox
-19.10% Stats
82 (1) Lunesta
Sunovion Pharmaceuticals Inc.
4.17% Stats
83 (1) Janumet
Merck & Co., Inc.
3.95% Stats
84 (11) Solodyn
Medicis Pharmaceutical Corporation
-7.87% Stats
85 (7) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc
16.27% Stats
86 Restasis
Allergan, Inc
8.79% Stats
87 (9) acetaminophen/hydrocodone
Generic
16.09% Stats
88 (11) Prevnar 13
Wyeth
-6.93% Stats
89 Velcade
Takeda Pharmaceuticals U.S.A., Inc
5.82% Stats
90 (42) Varivax
Merck & Co., Inc.
-36.43% Stats
91 () Pegasys
Genentech, Inc (member of Roche group)
Stats
92 (2) Opana ER
Endo Pharmaceuticals
7.28% Stats
93 (5) Zyvox
Pfizer Inc
1.17% Stats
94 (1) Benicar
Daiichi Sankyo
4.87% Stats
95 (11) Evista
Eli Lilly and Company
-4.69% Stats
96 (5) Xeloda
Roche Pharmaceuticals
1.39% Stats
97 (7) Erbitux
Bristol-Myers Squibb Company
-0.15% Stats
98 (2) Prezista
Janssen Pharmaceuticals, Inc
7.73% Stats
99 (12) Betaseron
Bayer Healthcare Pharmaceuticals
-3.76% Stats
100 (1) VESIcare
Astellas Pharma US
4.12% Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web2)